Daily Oncology News Alerts

Cancer Leaders Call for Congress to Act Quickly in 2015 to Reinvigorate Cancer Innovation in the U.S. (10/31/2014) - WASHINGTON, Oct. 30, 2014 /PRNewswire-USNewswire/ — Even before the next Congress is formally elected, a national group of healthcare stakeholders called the Cancer Innovation Coalition (CIC) took the unusual step of going to Capitol Hill to call for early legislative and regulatory action in 2015 that will reinvigorate cancer innovation in the U.S. The reason, […]
PhRMA Reports Show Promise, Challenges of Oncology Therapies (with Chart: Cancer Medicines in Development by Disease and Phase) (10/31/2014) - Pharmaceutical manufacturers are maintaining their research-and-development focus on oncology, with 771 therapies, including vaccines, in the pipeline, according to a new report from the Pharmaceutical Research and Manufacturers of America (PhRMA), released Oct. 7. And while many innovative products are coming onto the U.S. market, there are many more that fail during clinical trials. But […]
Dangerous Drug Shortages (10/31/2014) - Dozens of essential medications are in critically short supply. Here’s what you need to know Emergency medical technicians in Dayton, Ohio, have had such difficulty obtaining the seizure drug benzodiazepine the last few years that they’ve realized their best option is to “step on the gas and get to the hospital as quick as possible,” […]
Prostate Cancer Medications Linked with Increased Risk of Heart-Related Deaths in Men with Cardiovascular Problems (10/31/2014) - A new study has found that certain prostate cancer medications are linked with an increased risk of dying from heart-related causes in men with congestive heart failure or prior heart attacks. Published in BJU International, the findings will help doctors and patients weigh the benefits and risks of the drugs. Androgen deprivation therapy (ADT), which […]
Studies Find Cancer Medicines May Cure Facilities’ Bottom Line As Well As Patients’ Cancer (10/30/2014) - Two studies examined spending on oral anticancer drugs as well as the 340B program, a federal program designed to help the poor. The researchers say 340B designation helps hospitals boost profits. The first study, led by Rena M. Conti, PhD, of the University of Chicago in Illinois, examines recent trends in spending and use of […]
Google Developing a Pill That Would Detect Cancer and Other Diseases (10/30/2014) - LAGUNA BEACH, California — Google is attempting to develop a pill that would send microscopic particles into the bloodstream in an effort to identify cancers, imminent heart attacks, and other diseases. Andrew Conrad, the head of life sciences inside the company’s Google X research lab, revealed the project on Tuesday morning at a conference here […]
A New Cancer Drug Worked In Over 50% Of Patients In A Phase II Trial (10/30/2014) - A new cancer drug benefited 51% of stage III and IV melanoma patients during a phase II trial, achieving complete response (total cancer disappearance) in 26% during the treatment period. That was all in just 16 weeks of treatment, suggesting this drug has great potential for treating certain cancers in the future. During the study, […]
Therapy Treats Lung Cancer Based on Patients’ Genetic Markers (10/30/2014) - A new type of clinical trial for lung cancer patients getting under way at hospitals in the Bay Area and around the country may change the way drugs are tested in the future. That’s a pretty bold expectation, but researchers say the study — called the Lung Cancer Master Protocol, or Lung-MAP — will do […]